Oscar López, MD, FAAN, University of Pittsburgh, Pittsburgh, PA, discusses the use of blood-based biomarkers in the diagnosis of Alzheimer’s disease and talks on the possibility of a blood test being used in the future for the diagnosis of early-stage dementia. This interview took place at the American Academy of Neurology 2022 Congress in Seattle, WA.
